top of page

Strategic collaborations;

  • nvshah0610
  • Jul 5
  • 1 min read
ree

Dr. Reddy's continuous efforts to make innovative medicines available to patients in India and emerging markets to meet unmet needs and enhance the standard of care, we have partnered with several companies over the past few years – including Sanofi for vaccine distribution in India, Pharmazz for the first-in-class molecule Centhaquine, and Novartis Pharma to distribute two of their leading anti-diabetes brands, Galvus® and Galvus Met®, in the Russian retail market. These collaborations aim to bring novel medicines and strengthen our position in key therapeutic areas. They demonstrate our commitment to leveraging strategic partnerships to expand our portfolio, reach, and innovation in the Indian and global pharmaceutical landscape.

 Dr. Reddy's entered into a venture with Nestlé India to bring science-backed nutraceuticals to consumers across India. The venture focuses on a wide range of product segments, including metabolic health, hospital nutrition, general wellness, women's health, and child nutrition. Select brands such as Nature's Bounty, Osteo Bi-Flex, Ester-C, Resource High Protein, Optifast, Resource Diabetic, Peptamen, Resource Renal and Resource Dialysis of the Nestlé Group and brands such as Rebalanz, Celevida, Antoxid, Kidrich-D3, Becozinc from Dr. Reddy’s are part of this venture.

"We entered into a venture with Nestlé India to bring science-backed nutraceuticals to consumers across India. The venture focuses on a wide range of product segments, including metabolic health, hospital nutrition, general wellness, women's health, and child nutrition.", has been stated by Dr. Reddy's.

Comments


  • Instagram
bottom of page